Burckhardt Bjoern B, Ciplea Agnes Maria, Laven Anna, Ablonczy László, Klingmann Ingrid, Läer Stephanie, Kleine Karl, Dalinghaus Michiel, Đukić Milan, Breur Johannes M P J, van der Meulen Marijke, Swoboda Vanessa, Schwender Holger, Lagler Florian B
Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, Düsseldorf, Germany.
Pharmabrain Research and Training Center, Berlin, Germany.
Front Pharmacol. 2020 Dec 11;11:603042. doi: 10.3389/fphar.2020.603042. eCollection 2020.
: Pediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift. An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants' self-assessment before and during trial recruitment. The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded "LENA" project (grant agreement no. 602295). Self-perceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, ≤ 0.0001) from 3 (2.5-3.5) to four points (4.0-4.5), and from 2 (1.5-2.5) to five points (4.0-5.0). An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit.
为循证药物治疗补充缺失数据的儿科试验仍然很少。一个量身定制的培训概念似乎是一种很有前景的工具,可用于在招募首位患者之前应对关键和复杂的情况,并确保后续高质量的研究开展。其目的是通过优化研究人员轮班的准备工作来促进研究成功。一个跨学科教员团队开发了一种模拟培训,重点是知情同意程序中的沟通以及在模拟设施内进行复杂的药代动力学/药效学(PK/PD)采样。场景通过视听系统进行视频汇报,并使用带有模拟患者人造血液的人体模型。在试验招募之前和期间,通过参与者的自我评估对培训进行了评估。模拟培训确定了在改进知情同意过程和研究开展方面的不同优化潜力。它有助于减少可避免的错误,尤其是在临床研究的早期阶段。通过干预获得的知识被用于培训研究团队、改善团队构成,并为欧盟第七框架计划资助的“LENA”项目(资助协议编号602295)优化病房设置。自我感知的试验核心要素沟通能力以及样本制备的正确执行能力从3分(2.5 - 3.5)显著提高到4分(4.0 - 4.5)(均值,95%置信区间,≤0.0001),从2分(1.5 - 2.5)提高到5分(4.0 - 5.0)。一种优化知情同意过程和研究开展的创新培训概念得以成功开发,并从首位患者就诊起就实现了儿科试验的高质量开展。